Zobrazeno 1 - 10
of 71
pro vyhledávání: ''
Autor:
Furqan A. Bhullar, Aditya Ashok, Christopher Fan, Venkata S. Akshintala, Mouen A. Khashab, Niloofar Y Jalaly, Elham Afghani, Vikesh K. Singh, Ayesha Kamal, Mahya Faghih, Nasim Parsa, Francisco Garcia Gonzalez, Tina Boortalary, Atif Zaheer, Javad Azadi
Publikováno v:
Dig Dis Sci
BACKGROUND: Prior studies have evaluated clinical characteristics associated with opioid dose requirements in hospitalized patients with acute pancreatitis (AP) but did not incorporate morphologic findings on CT imaging. AIMS: We sought to determine
Autor:
Gerasimos J. Mantzaris, Eftychia Tsironi, Evgenia Koureta, Spyros I. Siakavellas, Konstantinos Makris, Giorgos Bamias, G Michalopoulos, Georgios Leonidakis, Maria Tzouvala, Christina Kapizioni, Nikolaos Kyriakos, Konstantinos Zografos, Nikos Viazis, Panagiotis Markopoulos, Ioannis Papaconstantinou, Konstantinos Karmiris, Michalis Gizis, Evanthia Zampeli, Emmanouela Tsoukali, Dimitrios Polymeros, Spyridon Michopoulos, Vassileios Xourafas, Konstantinos Triantafyllou, G Kokkotis, George V. Papatheodoridis, Eirini Zacharopoulou
Publikováno v:
Digestive Diseases and Sciences
Background Optimization of treatment with biologics is currently an unmet need for patients with ulcerative colitis (UC). Real-world studies provide neutral estimates of drug efficacy and safety within unselected patient populations and allow for the
Autor:
Ning-Sheng Lai, Kuo-Chih Tseng, Meng Hsuan Kuo, Chih-Wei Tseng, Kuang-Yung Huang, Ming-Chi Lu, Chien-Hsueh Tung, Chi-Hui Lee
Publikováno v:
Digestive Diseases and Sciences
Background and Aim To investigate the risk of hepatitis B virus reactivation in patients undergoing long-term tocilizumab therapy for rheumatoid arthritis. Method From January 2011 through August 2019, a total of 97 patients were enrolled in this ret
Autor:
Yuichi Matsuno, Tomohiko Moriyama, Takehiro Torisu, Keisuke Kawasaki, Motohiro Esaki, Takanari Kitazono, Yuta Fuyuno, Atsushi Hirano, Keizo Zeze, Shin Fujioka, Junji Umeno
Publikováno v:
Digestive Diseases and Sciences. 66:3124-3131
Although combining thiopurine with infliximab (IFX) is considered to improve the clinical efficacy of IFX when treating Crohn’s disease (CD), it also increases the risk of adverse events (AEs). We compared the efficacy and safety of delayed thiopur
Autor:
Shigetaka Yoshinaga, Ichiro Oda, Mai Ego, Seiichiro Abe, Satoru Nonaka, Yutaka Saito, Haruhisa Suzuki
Publikováno v:
Digestive Diseases and Sciences. 66:2336-2344
Antithrombotic therapy is a well-known independent risk factor for bleeding after endoscopic submucosal dissection (ESD) of early gastric cancer (EGC). A novel method of ulcer base closure using an endoloop and endoclips has been reported. This study
Autor:
Michael Camilleri, Richard F. Thomas, Jordan Sack, Jessica Atieh, Shilpa Grover, Osama E. Rahma
Publikováno v:
Dig Dis Sci
Immune checkpoint inhibitors (ICI) have improved outcomes in patients with various malignancies; however, they can cause immune-related hepatitis and enterocolitis. Patients on ICI may also develop upper gastrointestinal symptoms and undergo measurem
Autor:
Seung Bum Lee, Jung Woo Shin, Eun Ji Park, Neung Hwa Park, Joonho Jeong, Bo Ryung Park, Seok Won Jung, Min-Ju Kim
Publikováno v:
Digestive Diseases and Sciences. 66:1739-1750
Adherence to medication and maintained virologic response (MVR) are related to the risk of adverse clinical outcomes. This study aimed to compare the efficacy of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) in relation to the adverse clini
Autor:
Jeffrey A. Berinstein, Shail M. Govani, Karin M. Hardiman, Ryan W. Stidham, Akbar K. Waljee, Peter D.R. Higgins
Publikováno v:
Digestive Diseases and Sciences. 65:1800-1805
Infliximab can prevent colectomy in patients hospitalized with acute severe ulcerative colitis (ASUC). In cases of ASUC, fecal losses of infliximab may lead to low drug levels and reduced efficacy. To determine 90-day colectomy risk and postoperative
Publikováno v:
Digestive Diseases and Sciences. 65:1258-1265
Sedation during endoscopy in cirrhotic patients is typically via moderate sedation, most commonly using a combination of a benzodiazepine (i.e., midazolam) and narcotic (i.e., fentanyl) or with propofol using monitored anesthesia care (MAC). Here, we
Autor:
Pedro Cortés, Hassan Ghoz, Obaie Mzaik, Bhaumik Brahmbhatt, Muhamad Alhaj Moustafa, Maoyin Pang, Yan Bi, Nader D. Daoud
Publikováno v:
Digestive diseases and sciences. 67(6)
Sclerosing mesenteritis is a rare condition characterized by chronic inflammation and fibrotic changes of the mesentery. To determine the long-term management and outcomes of patients with sclerosing mesenteritis. Patients with biopsy-proven sclerosi